Armistice Capital »

Mattel shares owned by Armistice Capital

Quarter-by-quarter ownership of Mattel (MAT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Mattel

Tip: Access up to 7 years of quarterly data

All positions including Mattel held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mattel by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $817k 59k 13.88
2024-03-31 $507k 26k 19.81

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Mattel

Edgepoint Investment
PRIMECAP Management Company
BlackRock
Ariel Investments
Vanguard Capital Management
Vanguard Portfolio Management
Dimensional Fund Advisors
Southeastern Asset Management
State Street Corporation
LSV Asset Management
T. Rowe Price Associates
Alyeska Investment Group
Geode Capital Management
Hanna Zanoni
Goldman Sachs Group

View all funds holding Mattel